Bylvay® (odevixibat) is approved for the treatment of pruritus in PFIC in the U.S. and for PFIC in Europe. Elobixibat is approved for chronic constipation in Japan and Thailand. All other drugs and indications are currently investigational.
The link you have selected will take you outside of Albireo Pharma’s corporate website. The site you will be entering is intended for U.S. audiences only.